ArticleStem cell reports2019

Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes.

Sanam Shafaattalab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.